Former   CFO Howard Schiller testified at the same hearing as Koch, but   unlike Koch, he was on the defensive. ’ ’   ’ "    However, former CEO Michael Pearson touted the company’s low tax   rate as a selling point when the company was making a   hostile bid for Allergan.   